Cancer de l’endomètre de stade localisé : la perspective d’une désescalade thérapeutique guidée par la classification moléculaire

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancer radiothérapie 2022-10, Vol.26 (6-7), p.931-937
Hauptverfasser:	Espenel, S., Pointreau, Y., Genestie, C., Durdux, C., Haie-Meder, C., Chargari, C.
Format:	Artikel
Sprache:	eng ; fre
Schlagworte:	Life Sciences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	937
container_issue	6-7
container_start_page	931
container_title	Cancer radiothérapie
container_volume	26
creator	Espenel, S. Pointreau, Y. Genestie, C. Durdux, C. Haie-Meder, C. Chargari, C.
description
doi_str_mv	10.1016/j.canrad.2022.06.007
format	Article
fullrecord	<record><control><sourceid>hal_cross</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_04522183v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>oai_HAL_hal_04522183v1</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1257-d7cdabeb05eb83b063b9c7bae579892d58755ec1a6c0096cd4866cb8901eed8a3</originalsourceid><addsrcrecordid>eNo9kD1Ow0AQRi0EEuHnBhRuKWxm7ex6TRdFQJAi0UC9Gq8nsJFjm10biY4DcAE6SnINfBNOwlpBVDP65n1TvCA4YxAzYOJiHWusLZZxAkkSg4gBsr1gwjKRR0Jwue_3JJNRmjB5GBw5twYAIXI-Cd7nWGuyYUlh9fP2QXXZbIavztKYuA7HvNFYGTdsvz8vwwrDlqxrSXfmxUO-09d-DltHznNjoXsathZb6jvz3FP42Bt_prBFO9Z1hc6ZldHYmaYON001bHVfobF0EhyssHJ0-jePg4frq_v5Ilre3dzOZ8tIs4RnUZnpEgsqgFMh0wJEWuQ6K5B4lss8KbnMOCfNUGiAXOhyKoXQhcyBEZUS0-PgfPf3CSvVWrNB-6oaNGoxW6oxgylPvKv0hXl2umO1bZyztPovMFCjfbVWO_tqtK9AKG8__QWBj4QP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cancer de l’endomètre de stade localisé : la perspective d’une désescalade thérapeutique guidée par la classification moléculaire</title><source>Elsevier ScienceDirect Journals</source><creator>Espenel, S. ; Pointreau, Y. ; Genestie, C. ; Durdux, C. ; Haie-Meder, C. ; Chargari, C.</creator><creatorcontrib>Espenel, S. ; Pointreau, Y. ; Genestie, C. ; Durdux, C. ; Haie-Meder, C. ; Chargari, C.</creatorcontrib><identifier>ISSN: 1278-3218</identifier><identifier>EISSN: 1769-6658</identifier><identifier>DOI: 10.1016/j.canrad.2022.06.007</identifier><language>eng ; fre</language><publisher>Elsevier Masson</publisher><subject>Life Sciences</subject><ispartof>Cancer radiothérapie, 2022-10, Vol.26 (6-7), p.931-937</ispartof><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1257-d7cdabeb05eb83b063b9c7bae579892d58755ec1a6c0096cd4866cb8901eed8a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://hal.science/hal-04522183$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Espenel, S.</creatorcontrib><creatorcontrib>Pointreau, Y.</creatorcontrib><creatorcontrib>Genestie, C.</creatorcontrib><creatorcontrib>Durdux, C.</creatorcontrib><creatorcontrib>Haie-Meder, C.</creatorcontrib><creatorcontrib>Chargari, C.</creatorcontrib><title>Cancer de l’endomètre de stade localisé : la perspective d’une désescalade thérapeutique guidée par la classification moléculaire</title><title>Cancer radiothérapie</title><subject>Life Sciences</subject><issn>1278-3218</issn><issn>1769-6658</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNo9kD1Ow0AQRi0EEuHnBhRuKWxm7ex6TRdFQJAi0UC9Gq8nsJFjm10biY4DcAE6SnINfBNOwlpBVDP65n1TvCA4YxAzYOJiHWusLZZxAkkSg4gBsr1gwjKRR0Jwue_3JJNRmjB5GBw5twYAIXI-Cd7nWGuyYUlh9fP2QXXZbIavztKYuA7HvNFYGTdsvz8vwwrDlqxrSXfmxUO-09d-DltHznNjoXsathZb6jvz3FP42Bt_prBFO9Z1hc6ZldHYmaYON001bHVfobF0EhyssHJ0-jePg4frq_v5Ilre3dzOZ8tIs4RnUZnpEgsqgFMh0wJEWuQ6K5B4lss8KbnMOCfNUGiAXOhyKoXQhcyBEZUS0-PgfPf3CSvVWrNB-6oaNGoxW6oxgylPvKv0hXl2umO1bZyztPovMFCjfbVWO_tqtK9AKG8__QWBj4QP</recordid><startdate>202210</startdate><enddate>202210</enddate><creator>Espenel, S.</creator><creator>Pointreau, Y.</creator><creator>Genestie, C.</creator><creator>Durdux, C.</creator><creator>Haie-Meder, C.</creator><creator>Chargari, C.</creator><general>Elsevier Masson</general><scope>AAYXX</scope><scope>CITATION</scope><scope>1XC</scope></search><sort><creationdate>202210</creationdate><title>Cancer de l’endomètre de stade localisé : la perspective d’une désescalade thérapeutique guidée par la classification moléculaire</title><author>Espenel, S. ; Pointreau, Y. ; Genestie, C. ; Durdux, C. ; Haie-Meder, C. ; Chargari, C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1257-d7cdabeb05eb83b063b9c7bae579892d58755ec1a6c0096cd4866cb8901eed8a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; fre</language><creationdate>2022</creationdate><topic>Life Sciences</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Espenel, S.</creatorcontrib><creatorcontrib>Pointreau, Y.</creatorcontrib><creatorcontrib>Genestie, C.</creatorcontrib><creatorcontrib>Durdux, C.</creatorcontrib><creatorcontrib>Haie-Meder, C.</creatorcontrib><creatorcontrib>Chargari, C.</creatorcontrib><collection>CrossRef</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Cancer radiothérapie</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Espenel, S.</au><au>Pointreau, Y.</au><au>Genestie, C.</au><au>Durdux, C.</au><au>Haie-Meder, C.</au><au>Chargari, C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cancer de l’endomètre de stade localisé : la perspective d’une désescalade thérapeutique guidée par la classification moléculaire</atitle><jtitle>Cancer radiothérapie</jtitle><date>2022-10</date><risdate>2022</risdate><volume>26</volume><issue>6-7</issue><spage>931</spage><epage>937</epage><pages>931-937</pages><issn>1278-3218</issn><eissn>1769-6658</eissn><pub>Elsevier Masson</pub><doi>10.1016/j.canrad.2022.06.007</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1278-3218
ispartof	Cancer radiothérapie, 2022-10, Vol.26 (6-7), p.931-937
issn	1278-3218 1769-6658
language	eng ; fre
recordid	cdi_hal_primary_oai_HAL_hal_04522183v1
source	Elsevier ScienceDirect Journals
subjects	Life Sciences
title	Cancer de l’endomètre de stade localisé : la perspective d’une désescalade thérapeutique guidée par la classification moléculaire
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T03%3A28%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-hal_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cancer%20de%20l%E2%80%99endom%C3%A8tre%20de%20stade%20localis%C3%A9%C2%A0:%20la%20perspective%20d%E2%80%99une%20d%C3%A9sescalade%20th%C3%A9rapeutique%20guid%C3%A9e%20par%20la%20classification%20mol%C3%A9culaire&rft.jtitle=Cancer%20radioth%C3%A9rapie&rft.au=Espenel,%20S.&rft.date=2022-10&rft.volume=26&rft.issue=6-7&rft.spage=931&rft.epage=937&rft.pages=931-937&rft.issn=1278-3218&rft.eissn=1769-6658&rft_id=info:doi/10.1016/j.canrad.2022.06.007&rft_dat=%3Chal_cross%3Eoai_HAL_hal_04522183v1%3C/hal_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true